The treatment of the cancer cells with cabozantinib and compound 4 at the same concentration significantly reduced the expression of c-MET and its phosphorylation in a time-dependent manner, and such change by compound 4 was much greater than by cabozantinib (Figure 4B). Here, MET is linked to cancer.